Insider trades
Andrew Hollman Meyer, Chief Officer of Janux Therapeutics JANX, has filed 0 purchases and 19 sales on the open market. Over the past 12 months that comes to a net sale of $736.7K. The latest trade was on 01/02.
Andrew Hollman Meyer
Chief Business Officer
- Company
- Janux Therapeutics JANX
- First filing
- 23/01/05
- Trades
- 45 trades
- Buys / sales
- 0 / 19
- 12-month net buying
- −$736.7K
- Last trade
- 01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 01/02 | 01/02 | 1,879 sh | $13.73 | $25,798.67 | −2.2% | |
JANX | Open-market sale10b5-1 plan | 25/12/01 | 25/12/03 | 3,333 sh2 trades | $32.98avg. | $109,913.16 | −3.8% |
| Open-market sale10b5-1 plan | 25/11/14 | 25/11/14 | 3,333 sh | $30.00 | $99,990 | −3.8% | |
| Open-market sale10b5-1 plan | 25/10/28 | 25/10/30 | 16,665 sh | $30.06 | $500,949.9 | −16.9% | |
JANX | Open-market sale10b5-1 plan | 25/05/01 | 25/05/02 | 3,333 sh2 trades | $32.03avg. | $106,749.35 | −3.9% |
| Open-market sale10b5-1 plan | 25/04/21 | 25/04/23 | 3,334 sh | $30.00 | $100,020 | −3.9% | |
JANX | Open-market sale10b5-1 plan | 25/03/03 | 25/03/05 | 3,334 sh2 trades | $32.14avg. | $107,161.89 | −3.9% |
JANX | Open-market sale10b5-1 plan | 25/02/03 | 25/02/05 | 3,334 sh3 trades | $42.29avg. | $141,009.76 | −3.9% |
JANX | Open-market sale | 25/01/02 | 25/01/03 | 13,334 sh5 trades | $54.88avg. | $731,791.84 | −14.0% |
| Open-market sale | 24/09/27 | 24/09/27 | 50,000 sh | $45.96 | $2,298,000 | −42.5% |